Anna Gambaro

416 total citations
30 papers, 199 citations indexed

About

Anna Gambaro is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Anna Gambaro has authored 30 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Infectious Diseases. Recurrent topics in Anna Gambaro's work include HER2/EGFR in Cancer Research (10 papers), Cancer Treatment and Pharmacology (9 papers) and Advanced Breast Cancer Therapies (7 papers). Anna Gambaro is often cited by papers focused on HER2/EGFR in Cancer Research (10 papers), Cancer Treatment and Pharmacology (9 papers) and Advanced Breast Cancer Therapies (7 papers). Anna Gambaro collaborates with scholars based in Italy, United States and United Kingdom. Anna Gambaro's co-authors include Raffaella Palumbo, Cristina Teragni, Federico Sottotetti, Antônio Bernardo, Barbara Tagliaferri, Davide Dalu, Eliana Rulli, Marina Elena Cazzaniga, Nicla La Verde and E. Biraghi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Anna Gambaro

26 papers receiving 193 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Gambaro Italy	8	144	75	63	35	16	30	199
Mihai Vasile Marinca Romania	8	136 0.9×	66 0.9×	57 0.9×	57 1.6×	12 0.8×	31	253
Talal El Zarif United States	8	54 0.4×	45 0.6×	33 0.5×	53 1.5×	10 0.6×	28	163
Muriel Duluc France	6	147 1.0×	35 0.5×	40 0.6×	102 2.9×	18 1.1×	11	225
Bas Franken Netherlands	5	182 1.3×	48 0.6×	152 2.4×	49 1.4×	14 0.9×	7	246
Omar Abdihamid United States	8	79 0.5×	81 1.1×	45 0.7×	74 2.1×	11 0.7×	27	197
Jee‐Soo Lee South Korea	6	62 0.4×	30 0.4×	60 1.0×	64 1.8×	26 1.6×	24	164
R. Comas Spain	6	118 0.8×	45 0.6×	24 0.4×	93 2.7×	11 0.7×	11	194
Anna D. Louie United States	9	58 0.4×	48 0.6×	62 1.0×	122 3.5×	11 0.7×	16	217
Diletta Fontana Italy	7	82 0.6×	96 1.3×	25 0.4×	88 2.5×	16 1.0×	19	186
Johanna Mondésir France	4	41 0.3×	34 0.5×	69 1.1×	96 2.7×	16 1.0×	8	193

Countries citing papers authored by Anna Gambaro

Since Specialization

Citations

This map shows the geographic impact of Anna Gambaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gambaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gambaro more than expected).

Fields of papers citing papers by Anna Gambaro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Gambaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gambaro. The network helps show where Anna Gambaro may publish in the future.

Co-authorship network of co-authors of Anna Gambaro

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Gambaro. A scholar is included among the top collaborators of Anna Gambaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Gambaro. Anna Gambaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruggieri, Lorenzo, Ottavia Amato, Davide Dalu, et al.. (2024). Rising Concern About the Carcinogenetic Role of Micro-Nanoplastics. International Journal of Molecular Sciences. 26(1). 215–215. 1 indexed citations

Ruggieri, Lorenzo, Anna Lisa Ridolfo, Sara Giordana Rimoldi, et al.. (2024). Ralstonia insidiosa Bacteremia in Patients with Solid Cancer Treated by Means of a Central Venous Catheter. SHILAP Revista de lepidopterología. 4(2). 157–163. 1 indexed citations

Carriero, Serena, et al.. (2024). Diagnostic Performance of Kaiser score in MRI BI-RADS 3 Lesions: A Promising tool to reduce unnecessary biopsies. European Journal of Radiology. 183. 111872–111872.

Cona, Maria Silvia, Lorenzo Ruggieri, Salvatore Artale, et al.. (2024). 390P SARELIFE: An Italian, multicentric real-world study of sacituzumab govitecan (SG) in pretreated metastatic triple-negative breast cancer (mTNBC). Annals of Oncology. 35. S381–S382. 1 indexed citations

Cona, Maria Silvia, Agostino Riva, Davide Dalu, et al.. (2023). Clinical efficacy of the first two doses of anti‐SARS‐CoV‐2 mRNA vaccines in solid cancer patients. Cancer Medicine. 12(12). 12967–12974. 5 indexed citations

Ruggieri, Lorenzo, Anna Moretti, Rossana Berardi, et al.. (2023). Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians. International Journal of Molecular Sciences. 24(5). 4974–4974. 5 indexed citations

Verde, Nicla La, Giovanni Casazza, Stefania Cheli, et al.. (2021). Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients. The Pharmacogenomics Journal. 21(4). 491–497. 3 indexed citations

Torrisi, Rosalba, Raffaella Palumbo, Rita De Sanctis, et al.. (2021). Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9). Breast Cancer Research and Treatment. 190(1). 103–109. 2 indexed citations

Cona, Maria Silvia, Eliana Rulli, Davide Dalu, et al.. (2021). The emotional impact of the COVID-19 outbreak on cancer outpatients and their caregivers: results of a survey conducted in the midst of the Italian pandemic. Supportive Care in Cancer. 30(2). 1115–1125. 7 indexed citations

10.

Palumbo, Raffaella, Rosalba Torrisi, Federico Sottotetti, et al.. (2021). Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study. Therapeutic Advances in Medical Oncology. 13. 3863602691–3863602691. 17 indexed citations

11.

Cona, Maria Silvia, et al.. (2020). 1570P The emotional impact of COVID-19 outbreak on cancer out-patients and their caregivers: Impressions from the heart of the Italian pandemic. Annals of Oncology. 31. S956–S957.

12.

Dalu, Davide, Maria Silvia Cona, Anna Maria Brambilla, et al.. (2020). A proposal of a “ready to use” COVID-19 control strategy in an Oncology ward: Utopia or reality?. Critical Reviews in Oncology/Hematology. 157. 103168–103168. 7 indexed citations

13.

Dalu, Davide, V. Filipazzi, Anna Gambaro, et al.. (2019). ABCB1 c.3435C>T polymorphism is associated with platinum toxicity: a preliminary study. Cancer Chemotherapy and Pharmacology. 83(4). 803–808. 11 indexed citations

14.

Bernardo, Antônio, Raffaella Palumbo, Rebecca Pedersini, et al.. (2017). Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials. Clinical Breast Cancer. 17(6). 433–440. 6 indexed citations

15.

Quaquarini, Erica, Federico Sottotetti, Anna Gambaro, et al.. (2017). Comorbidity scores as predictive tools for nivolumab toxicity in patients with advanced non small cell lung cancer (NSCLC): preliminary results of a prospective multicenter study. Annals of Oncology. 28. vi60–vi60. 1 indexed citations

16.

Cazzaniga, Marina Elena, Laura Cortesi, Laura Scaltriti, et al.. (2016). Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study. Breast Cancer Research and Treatment. 160(3). 501–509. 43 indexed citations

17.

Gambaro, Anna, Federico Sottotetti, Luca Licata, et al.. (2016). Patterns of treatment and outcome of fulvestrant 500mg in postmenopausal women with hormone-positive (HR+)/Her2-negative (HER2-) metastatic breast cancer (MBC): a real life multicenter Italian experience. Annals of Oncology. 27. vi82–vi82. 1 indexed citations

18.

Palumbo, Raffaella, Federico Sottotetti, Giuseppe Trifirò, et al.. (2015). Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life. Drug Design Development and Therapy. 9. 2189–2189. 34 indexed citations

19.

Verde, Nicla La, Fabio Corsi, Anna Moretti, et al.. (2015). A Targeted Approach to Genetic Counseling in Breast Cancer Patients: The Experience of an Italian Local Project. Tumori Journal. 102(1). 45–50. 6 indexed citations

20.

Oteri, Alessandro, María Teresa Cattaneo, V. Filipazzi, et al.. (2009). A Case of Bullous Dermatitis Induced by Erlotinib. The Oncologist. 14(12). 1201–1204. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact